PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Octagon Research Solutions, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Octagon Research Solutions, Inc. Expands CDISC Expertise with Industry Veterans - Octagon Research Solutions, Inc., today announced the appointment of Ms. Mary Lenzen and Dr. Frederick Wood as principal consultants in Octagon's Clinical Data Strategies division.
Octagon Research Solutions, Inc. Expands CDISC Expertise with Industry Veterans

 

NewswireToday - /newswire/ - Wayne, PA, United States, 2006/08/01 - Octagon Research Solutions, Inc., today announced the appointment of Ms. Mary Lenzen and Dr. Frederick Wood as principal consultants in Octagon's Clinical Data Strategies division..

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

CEO & Chairman, Jim Walker of Octagon Research Solutions, Inc., a pioneer and leader in the electronic transformation of clinical R&D in the life sciences industry, today announced the appointment of Ms. Mary Lenzen and Dr. Frederick Wood as principal consultants in Octagon’s Clinical Data Strategies division. In their new roles, Ms. Lenzen and Dr. Wood will oversee CDISC training initiatives and spearhead the company’s broader efforts to continue building on its leadership position in CDISC conversions, training, and thought leadership worldwide, reaffirming its commitment to the highest levels of data standards professionalism and support.

Octagon Research Solutions, Inc. is a proud corporate sponsor of CDISC (Clinical Data Interchange Standards Consortium), a collaborative working group made up of representatives from industry and the FDA. CDISC’s mission is to lead the development and support of global, platform-independent data standards that enable information system interoperability to improve medical research and related areas of healthcare.

“Mary and Fred are an unparalleled set of assets to provide training and consulting on CDISC standards and initiatives,” stated Tom Guinter, vice president of Clinical Data Strategies, “No other company has this breadth of knowledge, resources, and tools to help the industry adopt these standards. CDISC is on a real growth track and I am excited that Mary and Fred have chosen to be part of the Octagon team.“

Both Mary and Fred have been members of the CDISC Submission Data Standards (SDS) Team since its inception in 1999, and have served as Team Co-Chairs for the past four years. The SDS Team produced the Study Data Tabulation Model (SDTM), and in 2005 received the Leveraging/Collaboration Award from the FDA ‘For creation of the standard Study Data Tabulation Model (SDTM) and accompanying implementation guide for submission of data tabulation datasets.’ Mary and Fred are members of the Standards Review Board, a leadership team within CDISC that has the responsibility for reviewing and approving any changes or enhancements to SDTM.

Ms. Lenzen most recently was the leader of global Clinical Data Standards at Pfizer, Inc., where she managed and led technical staff to support data standards for clinical data encompassing the clinical trial process from development through marketed drugs. Ms. Lenzen has almost 30 years of pharmaceutical industry experience combined with a Master’s degree in Computer Science. In addition, she is a key contributor for the CDISC controlled terminology initiative. While at Pfizer, she represented Pfizer on the CDISC Industry Advisory Board.

Dr. Wood was most recently global data standards manager, Clinical Data & Information Management, at Procter & Gamble Pharmaceuticals, where he led efforts to develop company-wide data standards. His CDISC involvement also includes membership on the CDISC Production Standards Coordinating Committee and the CDISC Industry Advisory Board. Dr. Wood has also had a leadership role on the CDISC SEND (Standards for the Exchange of Nonclinical Data) Team.

During his tenure at Procter & Gamble Pharmaceuticals, Mr. Wood received numerous awards and citations including the CDISC Outstanding Achievement Award for the Submission Data Standards (SDS) Team in 2000 and 2004, and for the SEND Team in 2004 and 2005.

“Today’s appointments demonstrate our ability to attract the industry’s best and brightest talent, and reaffirm our commitment to creating and providing the most innovative suite of services backed by industry-leading training and leading edge technologies,” added Jim Walker.

About Octagon Research Solutions, Inc.
Octagon is a pioneer and leading process-centric solutions provider that offers a suite of regulatory, clinical, process, and IT solutions to the life sciences industry. Octagon synchronizes processes and increases automation to reduce island-to-island inefficiencies within the clinical research and development process. We leverage the power of electronic submissions through cross-functional electronic submission expertise, a holistic process approach, deep domain knowledge, and integrated solutions. Octagon is headquartered in Wayne, PA, with offices in Boston, MA; Costa Mesa, CA; and European headquarters in Amersham, UK.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Octagon Research Solutions, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Octagon Research Solutions, Inc. Expands CDISC Expertise with Industry Veterans

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Jim Graham 
610 535 6500 / 5655 jgraham[.]octagonresearch.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Octagon Research Solutions, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Octagon Research Solutions, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)